Luminata Archives - Page 4 of 7

Consolidating and Managing Data for Drug Development within a Pharmaceutical Laboratory: Comparing the Mapping and Reporting Tools from Software Applications

nvision Sep 14, 2021

This article compares the use of Luminata and Microsoft Excel for consolidating and managing all the analytical data in pharmaceutical drug development.

Using software to improve data management and output in pharma development

Joel Michalski Jul 5, 2021

In this article Jordan Stobaugh from AbbVie talks about their reasons for rolling out Luminata and their continued work to improve their efficiency in process development with the help of informatics tools.

Dealing with Data Paralysis in Pharmaceutical Process Development

Joel Michalski Jun 17, 2021

Data management in process chemistry and engineering can feel like a full-time job without the right tools. Watch our webinar, where Mathew Mulhern (AbbVie Pharmaceuticals) and Joe DiMartino (ACD/Labs) present how Luminata from ACD/Labs simplifies data management.

Data Management and Drug Quality in Pharmaceutical Manufacturing

Jesse Harris Apr 29, 2021

This article provides an overview of why digitalized data management in the pharmaceutical industry is challenging and explores how effective data management can enhance drug quality.

Evaluating Your Technology Toolbox

Joel Michalski Apr 23, 2021

What technology do you use at work? How well does it work for you? And what tech are you hoping and praying will land on your lab bench or computer one day? Technology scouting is the process of identifying gaps in a business that can be filled with new tech. Maybe it’s the manual copying-and-pasting...

Addressing the Unique Challenges of Data Management in ADC Development

nvision Mar 29, 2021

Critically Examining Data Management in ADC Development and Research Antibody Drug Conjugates (ADCs) are a class of therapeutics that utilizes the specificity of monoclonal antibody (mAB) to enable targeted drug delivery. With more than 180 ADCs currently in clinical trials, the ADC market is predicted to grow from $2-3 billion today to over $13 billion...

Trends in Antibody-Drug Conjugate Development and Data Management

Jesse Harris Mar 25, 2021

Eliot Randle and Joe DiMartino discuss why biopharmaceutical companies are excited about Antibody-Drug Conjugates (ADCs), and how collaborative development is strategically important in ADC research.

Data explosion leads to opportunities, obstacles

Joel Michalski Dec 16, 2020

Andrew Anderson from ACD/Labs, a small-molecule solutions company, explains how the ever-increasing mountain of life-sciences data has impacted drug development.

Creating a Scientific Information Library Using ACD/Spectrus Platform

Joel Michalski Dec 9, 2020

The wealth of analytical information that is generated every day in R&D organizations can provide rich insights, even months after the initial acquisition of data. With this increase in data, however, comes a significant challenge to combine, organize, access, visualize, and mine these informational repositories. In addition to the challenges of the growing volume and...

Uma abordagem QbD (Quality by Design) com Redução de Investimentos e Tempo no Gerenciamento de Dados de Impurezas

Joel Michalski Dec 4, 2020

Se você está envolvido no Desenvolvimento de Novos Fármacos, este Webinar é para você. O desenvolvimento de processos farmacêuticos envolve grupos multidisciplinares de químicos e analistas cujo objetivo é produzir Ingrediente(s) Farmacêutico(s) Ativo(s) – IFAs de acordo com a rota mais econômica e eficiente, garantindo a segurança do produto por meio de medidas eficazes de...

ACD/Labs Blog